Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
Y NaritomiA Kagayama

Abstract

1. The identification and relative contributions of human cytochrome P450 (CYP) enzymes involved in the metabolism of glibenclamide and lansoprazole in human liver microsomes were investigated using an approach based on the in vitro disappearance rate of unchanged drug. 2. Recombinant CYP2C19 and CYP3A4 catalysed a significant disappearance of both drugs. When the contribution of CYPs to the intrinsic clearance (CL(int)) of drugs in pooled human microsomes was estimated by relative activity factors, contributions of CYP2C19 and CYP3A4 were determined to be 4.6 and 96.4% for glibenclamide, and 75.1 and 35.6% for lansoprazole, respectively. 3. CL(int) of glibenclamide correlated very well with CYP3A4 marker activity, whereas the CL(int) of lansoprazole significantly correlated with CYP2C19 and CYP3A4 marker activities in human liver microsomes from 12 separate individuals. Effects of CYP-specific inhibitors and anti-CYP3A serum on the CL(int) of drugs in pooled human liver microsomes reflected the relative contributions of CYP2C19 and CYP3A4. 4. The results suggest that glibenclamide is mainly metabolized by CYP3A4, whereas lansoprazole is metabolized by both CYP2C19 and CYP3A4 in human liver microsomes. This approach, based on t...Continue Reading

References

Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·J A van EekelenE R de Kloet
Mar 1, 1991·Chemical Research in Toxicology·F P GuengerichM Iwasaki
Nov 1, 1990·Chemical Research in Toxicology·R PeterC S Yang
Mar 1, 1995·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S J BaldwinR J Chenery
Oct 1, 1996·Journal of Pharmacokinetics and Biopharmaceutics·F P Guengerich
Jan 1, 1997·European Journal of Clinical Pharmacology·H KatsukiM Nakano
Dec 5, 1998·Clinical Pharmacokinetics·J H Lin, A Y Lu
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hisashi SuzukiAllan E Rettie
Mar 11, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert L Walsky, R Scott Obach
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoichi NaritomiYuichi Sugiyama

❮ Previous
Next ❯

Citations

Apr 17, 2013·Molecular Diagnosis & Therapy·C F SamerJ A Desmeules
Jul 2, 2009·Journal of Cardiovascular Pharmacology·Adam B AdamopoulosGeorge S Stergiou
Jun 19, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lin ZhouQingcheng Mao
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Andreas Holstein, Winfried Beil
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Dec 15, 2010·Thérapie·Leila ChebaneUNKNOWN Centres Régionaux de Pharmacovigilance Français
Apr 28, 2007·Biochemical Pharmacology·Olga L ZharikovaMahmoud S Ahmed
Mar 20, 2009·Clinical Pharmacology and Therapeutics·M F HebertUNKNOWN Obstetric-Fetal Pharmacology Research Unit Network
Mar 29, 2012·British Journal of Clinical Pharmacology·J G Coen van HasseltDonald R Mattison
May 4, 2010·Biopharmaceutics & Drug Disposition·Lin ZhouQingcheng Mao
Dec 1, 2006·Chemico-biological Interactions·María José Gómez-LechónMaría Teresa Donato
Apr 6, 2012·Trends in Pharmacological Sciences·Aleksi TornioJanne T Backman
May 28, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·L B GersonG Triadafilopoulos
Mar 3, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Gregory OndiekiXin He
Jan 1, 2011·Pharmaceutics·Sabine KlattJörg König
Apr 26, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rui LiManthena V S Varma
Apr 28, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J-M NicolasA Stockis
Apr 29, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Makiko KusamaYuichi Sugiyama
Aug 18, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Yousef A Bin JardanFahad I Al-Jenoobi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.